Subscribe to RSS

DOI: 10.1590/0004-282X-ANP-2021-0422
Proton spectroscopy: a simple and useful tool in the investigation of mitochondrial disease
Espectroscopia de prótons: uma ferramenta simples e útil na investigação de doença mitocondrial
A 38-year-old woman presented to the emergency department with right hemiparesis. Brain computed tomography (CT) and magnetic resonance imaging (MRI) were recommended ([Figures 1] and [2]). Genetic study confirmed the presence of a point mutation m.3243 A>G of mtDNA, confirming the diagnosis of Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS).




MELAS is a rare mitochondrial disorder that can be manifested by stroke-like episodes, epilepsy, hyperlactatemia, myopathy, headaches, deafness, diabetes, and short stature[1]. Although not pathognomonic, the lactate peak observed in spectroscopy can be an indication for MELAS diagnosis, which is found to be correlated with the severity of clinical manifestations[2]. Genetic testing confirms the diagnosis[3].
Authors’ contributions:
DVN, LFRV: design or conceptualization of the study, analysis or interpretation of the data, and drafting or revising the manuscript for intellectual content.
Publication History
Received: 16 October 2021
Accepted: 28 November 2021
Article published online:
06 February 2023
© 2022. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015; Sep-Oct; 116(1-2) 4-12 https://doi.org/10.1016/j.ymgme.2015.06.004
- 2 Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E. et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology. 2004; Apr; 62 (08) 1297-302 https://doi.org/10.1212/01.wnl.0000120557.83907.a8
- 3 Lorenzoni PJ, Werneck LC, Kay CSK, Silvado CES, Scola RH. When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes) be the diagnosis?. Arq Neuro-Psiquiatr. 2015; Nov; 73 (11) 959-67 https://doi.org/10.1590/0004-282X20150154